Palladium-103 is a radioisotope of the element palladium which has uses in radiation therapy for prostate cancer and uveal melanoma. Palladium-103 may be created from palladium-102. It has a half-life of 16.99 days and decays by electron capture to rhodium-103, emitting gamma-rays with 21 keV of energy.
Read more about this topic: Isotopes Of Palladium